Alexion Pharmaceuticals Analysis
Alexion Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Alexion Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what Alexion Pharmaceuticals is worth, separate from its market price. There are two main types of Alexion Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Alexion Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Alexion Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Alexion Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Alexion Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Alexion Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Alexion Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Alexion |
Alexion Stock Analysis Notes
About 88.0% of the company shares are held by institutions such as insurance companies. The book value of Alexion Pharmaceuticals was presently reported as 56.21. The company has Price/Earnings To Growth (PEG) ratio of 1.46. Alexion Pharmaceuticals had not issued any dividends in recent years. The entity had 2:1 split on the 23rd of May 2011. Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company was founded in 1992 and is headquartered in Boston, Massachusetts. Alexion Pharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3837 people. For more info on Alexion Pharmaceuticals please contact Ludwig Hantson at 475 230-2596 or go to www.alexion.com.Alexion Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Alexion Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Alexion Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Alexion Pharmaceuticals is not yet fully synchronised with the market data | |
| Alexion Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Alexion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Over 88.0% of the company shares are held by institutions such as insurance companies |
Alexion Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 39.66 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alexion Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Alexion Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Alexion Profitablity
Alexion Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Alexion Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Alexion Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Alexion Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Alexion Pharmaceuticals' profitability requires more research than a typical breakdown of Alexion Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 10.89 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 52.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $52.12. Alexion Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Alexion Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Alexion Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Alexion Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Carsten Thiel over a year ago Sale by Carsten Thiel of 1000 shares of Alexion Pharmaceuticals |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Alexion Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Alexion Stock
If you are still planning to invest in Alexion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alexion Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |